Article ; Online: Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.
2020 Volume 144, Page(s) 110020
Abstract: Pulmonary surfactant is considered to be one of the soaps. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the other enveloped viruses become very weak against surfactant. The SARS virus binds to angiotensin-converting enzyme (ACE2) ... ...
Abstract | Pulmonary surfactant is considered to be one of the soaps. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the other enveloped viruses become very weak against surfactant. The SARS virus binds to angiotensin-converting enzyme (ACE2) receptor and causes pneumonia. In the lung, the ACE2 receptor sits on the top of lung cells known as alveolar epithelial type II (AE2) cells. These cells play an important role in producing surfactant. Pulmonary surfactant is believed to regulate the alveolar surface tension in mammalian lungs. To our knowledge, AE2 cells are believed to act as immunoregulatory cells; however, pulmonary surfactant itself has not been believed to act as a defender against the enveloped viruses. This study hypothesises that pulmonary surfactant may be a strong defender of enveloped viruses. Therefore, old coronaviruses merely cause pneumonia. On the contrary, new SARS-CoV-2 can suppress the production of surfactant that binds to the ACE2 of AE2 cells. The coronavirus can survive in the lung tissue because of the exhaustion of pulmonary surfactant. |
---|---|
MeSH term(s) | Ambroxol/therapeutic use ; Angiotensin-Converting Enzyme 2/metabolism ; Bromhexine/therapeutic use ; COVID-19/drug therapy ; COVID-19/physiopathology ; COVID-19/prevention & control ; Clinical Trials as Topic ; Crystallography, X-Ray ; Humans ; Models, Theoretical ; Phagocytosis ; Pneumonia, Viral/physiopathology ; Pregnenediones/therapeutic use ; Pulmonary Alveoli/metabolism ; Pulmonary Surfactants/therapeutic use ; SARS-CoV-2 ; Surface Tension ; Surface-Active Agents |
Chemical Substances | Pregnenediones ; Pulmonary Surfactants ; Surface-Active Agents ; Ambroxol (200168S0CL) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Bromhexine (Q1J152VB1P) ; ciclesonide (S59502J185) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-06-20 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 193145-3 |
ISSN | 1532-2777 ; 0306-9877 |
ISSN (online) | 1532-2777 |
ISSN | 0306-9877 |
DOI | 10.1016/j.mehy.2020.110020 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1132: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.